A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Open accessAbstract
Objectives We prospectively investigated the prevalence of curable forms of primary aldosteronism (PA) in newly diagnosed hypertensive patients.Background The prevalence of curable forms of PA is currently unknown, although retrospective data suggest that it is not as low as commonly perceived.Methods Consecutive hypertensive patients referred to 14 hypertension centers underwent a diagnostic protocol composed of measurement of Na+ and K+ in serum and 24-h urine, sitting plasma renin activity, and aldosterone at baseline and after 50 mg captopril. The patients with an aldosterone/renin ratio >40 at baseline, and/or >30 after captopril, and/or a probability of PA (by a logistic discriminant function) > or =50% underwent imaging tests and adrenal vein sampling (AVS) or adrenocortical scintigraphy to identify the underlying adrenal pathology. An aldosterone-producing adenoma (APA) was diagnosed in patients who in addition to excess autonomous aldosterone secretion showed: 1) lateralized aldosterone secretion at AVS or adrenocortical scintigraphy, 2) adenoma at surgery and pathology, and 3) a blood pressure decrease after adrenalectomy. Evidence of excess autonomous aldosterone secretion without such criteria led to a diagnosis of idiopathic hyperaldosteronism (IHA).Results A total of 1,180 patients (age 46 +/- 12 years) were enrolled; a conclusive diagnosis was attained in 1,125 (95.3%). Of these, 54 (4.8%) had an APA and 72 (6.4%) had an IHA. There were more APA (62.5%) and fewer IHA cases (37.5%) at centers where AVS was available (p = 0.002); the opposite occurred where AVS was unavailable.Conclusions In newly diagnosed hypertensive patients referred to hypertension centers, the prevalence of APA is high (4.8%). The availability of AVS is essential for an accurate identification of the adrenocortical pathologies underlying PA.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Only 9% to 37% of patients with primary hyperaldosteronism were hypokalemic in a recent multicenter analysis.
“A recent multicenter analysis estimated that only 9% to 37% of patients with primary hyperaldosteronism were hypokalemic (276,277).”
From Adrenal incidentaloma (2020) · cites this paper as [277]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,638 · see citing works
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016 · see citing works
Subcommittee, G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,895 · see citing works
Guidelines Committee (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00001 · Cited by 3,015 · see citing works
Mancia, G., Rosei, E. A., Cífková, R., DeBacker, G., Erdine, S. E., Fagard, R., Farsang, C., Heagerty, A. M., Kawecka-Jaszcs, K., Kiowski, W., et al. (2003) · Lirias (KU Leuven) · doi:10.1097/01.hjh.0000059051.65882.32 · Cited by 2,601 · see citing works
Empirical evidence of design-related bias in studies of diagnostic tests.
Lijmer, J. G. (1999) · JAMA · doi:10.1001/jama.282.11.1061 · Cited by 1,861 · see citing works
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P., Irwig, L., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Clinical Chemistry · doi:10.1373/49.1.7 · Cited by 1,124 · see citing works
Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.
Conn, J. W. (1955) · PubMed · Cited by 963 · see citing works
Mulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961 · see citing works
Incidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869 · see citing works
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763 · see citing works
Role for adrenal venous sampling in primary aldosteronism
Young, W. F., Stanson, A. W., Thompson, G. B., Grant, C. S., Farley, D. R., & van Heerden, J. A. (2004) · Surgery · doi:10.1016/j.surg.2004.06.051 · Cited by 731 · see citing works
HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., & Rutherford, J. C. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02519.x · Cited by 495 · see citing works
Renal Damage in Primary Aldosteronism: Results of the PAPY Study
Rossi, G. P., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., Matterello, M.-J., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000230444.01215.6a · Cited by 470 · see citing works
Self-citationAnderson, G. H., Blakeman, N., & Streeten, D. H. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199405000-00015 · Cited by 403 · see citing works
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Mulatero, P., Rabbia, F., Milan, A., Paglieri, C., Morello, F., Chiandussi, L., & Veglio, F. (2002) · Hypertension · doi:10.1161/01.hyp.0000038478.59760.41 · Cited by 389 · see citing works
Prevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore1
Loh, K., Koay, E. S. C., Khaw, M.-C., Emmanuel, S. C., & Young, W. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6752 · Cited by 350 · see citing works
Adrenal Vein Sampling: How to Make It Quick, Easy, and Successful
Daunt, N. (2005) · Radiographics · doi:10.1148/rg.25si055514 · Cited by 315 · see citing works
Diagnosis and Treatment of Primary Hyperaldosteronism
Blumenfeld, J. D., Sealey, J. E., Schlussel, Y., Vaughan, E. D., Sos, T. A., Atlas, S. A., Muller, F. B., Acevedo, R., Ulick, S., & Laragh, J. H. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00010 · Cited by 301 · see citing works
Rossi, G. P., Sacchetto, A., D, M. C.-C. M., Toni, R. D., Gallina, M., Feltrin, G. P., & Pessina, A. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7287 · Cited by 287 · see citing works
Self-citationRemodeling of the Left Ventricle in Primary Aldosteronism Due to Conn’s Adenoma
Rossi, G. P., Sacchetto, A., Pavan, E., Palatini, P., Graniero, G. R., Canali, C., & Pessina, A. C. (1997) · Circulation · doi:10.1161/01.cir.95.6.1471 · Cited by 273 · see citing works
Self-citationIncidentally discovered adrenal masses
Kloos, R. T. (1995) · Endocrine Reviews · doi:10.1210/er.16.4.460 · Cited by 272 · see citing works
High prevalence of primary aldosteronism in the Tayside hypertension clinic population
Lim, P. O., Dow, E., Brennan, G., Jung, R., & MacDonald, T. M. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001013 · Cited by 268 · see citing works
Guidelines for the Reporting of Renal Artery Revascularization in Clinical Trials
Rundback, J. H., Sacks, D., Kent, K. C., Cooper, C. J., Jones, D. W., Murphy, T. P., Rosenfield, K., White, C. J., Bettmann, M. A., Cortell, S., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029805.87199.45 · Cited by 248 · see citing works
Magill, S. B., Raff, H., Shaker, J. L., Brickner, R. C., Knechtges, T. E., Kehoe, M. E., & Findling, J. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7282 · Cited by 247 · see citing works
Schwartz, G. L., & Turner, S. T. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.041780 · Cited by 221 · see citing works
Magill, S. B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1066 · Cited by 195 · see citing works
Gordon, R. D., Ziesak, M. D., Tunny, T. J., Stowasser, M., & Klemm, S. A. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb01687.x · Cited by 190 · see citing works
Prevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore
Loh, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2854 · Cited by 182 · see citing works
Saline Suppression of Plasma Aldosterone in Hypertension
Kem, D. C. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310210056004 · Cited by 180 · see citing works
Rossi, E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02969-2 · Cited by 164 · see citing works
Self-citationTiu, S.-C., Choi, C.-H., Shek, C. C., Ng, Y. W., Chan, F. K. W., Ng, C., & Kong, A. P. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1149 · Cited by 162 · see citing works
Aldosterone to Renin Ratio in a Primary Care Setting: The Bussolengo Study
Olivieri, O., Ciacciarelli, A., Signorelli, D., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032179 · Cited by 155 · see citing works
Giacchetti, G., Ronconi, V., Lucarelli, G., Boscaro, M., & Mantero, F. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217857.20241.0f · Cited by 154 · see citing works
Self-citationDiagnosis of primary aldosteronism: from screening to subtype differentiation
Mulatero, P., Dluhy, R. G., Giacchetti, G., Boscaro, M., Veglio, F., & Stewart, P. M. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.007 · Cited by 143 · see citing works
Self-citationAdrenal Incidentaloma: An Overview of Hormonal Data from the National Italian Study Group
Mantero, F., Masini, A. M., Opocher, G., Giovagnetti, M., & Arnaldi, G. (1997) · Hormone Research · doi:10.1159/000185478 · Cited by 139 · see citing works
Self-citationOmura, M., Sasano, H., Fujiwara, T., Yamaguchi, K., & Nishikawa, T. (2002) · Metabolism · doi:10.1053/meta.2002.30498 · Cited by 139 · see citing works
Aldosterone as a cardiovascular risk factor
Rossi, G. P., Boscaro, M., Ronconi, V., & Funder, J. W. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.010 · Cited by 135 · see citing works
Self-citationThe current epidemic of primary aldosteronism
Kaplan, N. M. (2004) · Journal of Hypertension · doi:10.1097/00004872-200405000-00001 · Cited by 120 · see citing works
Rossi, G. P., Ganzaroli, C., D, D. M. M., Toni, R. D., Palumbo, G., Feltrin, G. P., Mantero, F., & Pessina, A. C. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000202818.10459.96 · Cited by 120 · see citing works
Self-citationAldosterone as a Cardiovascular Risk Factor
Yoo, S. J. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.1.8 · Cited by 112 · see citing works
The current epidemic of primary aldosteronism
Spence, J. D. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00030 · Cited by 109 · see citing works
Ferriss, J. B. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92811-4 · Cited by 100 · see citing works
The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner, B. L., Opie, L. H., & Davidson, J. S. (2000) · PubMed · Cited by 95 · see citing works
Screening for primary aldosteronism with a logistic multivariate discriminant analysis*
Rossi, G. P., Rossi, E., Pavan, E., Rosati, N., Zecchel, R., Semplicini, A., Perazzoli, F., & Pessina, A. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00608.x · Cited by 83 · see citing works
Self-citationRayner, B. L., Myers, J. E., OPIE, L., et al. (2001) · PubMed · Cited by 59 · see citing works
Primary hyperaldosteronism: A missed diagnosis in ‘essential hypertensives’?
Brown, M. A., Cramp, H., Zammit, V. C., & Whitworth, J. A. (1996) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1996.tb00600.x · Cited by 57 · see citing works
Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study
Abdelhamid, S. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00858-6 · Cited by 57 · see citing works
Prevalence of Adrenal and Extra-adrenal Conn Syndrome in Hypertensive Patients
Abdelhamid, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440100086010 · Cited by 56 · see citing works
Effects of Nifedipine Treatment on the Renin-Angiotensin-Aldosterone Axis1
Fiad, T. M., Cunningham, S. K., Hayes, F. J., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3748 · Cited by 43 · see citing works
Primary aldosteronism: A needle in a haystack or a yellow cab on fifth avenue?
Rossi, G. P. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0001-0 · Cited by 41 · see citing works
Self-citationEffects of Nifedipine Treatment on the Renin-Angiotensin-Aldosterone Axis
Fiad, T. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.457 · Cited by 32 · see citing works
Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 14 · see citing works
Diagnosis and Treatment of Primary Aldosteronism
Rossi, G. P., Gregianin, M., & Chisura-Corona, M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-1-199507010-00013 · Cited by 9 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [20]20. Rossi GP, Bernini G, Desideri G, et al. Renal damage in primary aldosteronism. Hypertension 2006;48:232-8.
Cited by
Sorted by citations
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925 · see citing works
Self-citation2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298 · see citing works
Self-citationFunder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554 · see citing works
Self-citationProgram, T. M. V., Evangelou, E., Warren, H. R., Mosen-Ansorena, D., Mifsud, B., Pazoki, R., Gao, H., Ntritsos, G., Dimou, N., Cabrera, C. P., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0205-x · Cited by 1,381 · see citing works
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072 · see citing works
Scholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627 · see citing works
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577 · see citing works
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
Azizan, E. A. B., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M. V., Lieb, A., Maniero, C., Garg, S., Bochukova, E. G., Zhao, W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2716 · Cited by 544 · see citing works
Clase, C. M., Carrero, J.-J., Ellison, D. H., Grams, M. E., Hemmelgarn, B. R., Jardine, M. J., Kovesdy, C. P., Kline, G. A., Lindner, G., Obrador, G. T., et al. (2020) · Kidney International · doi:10.1016/j.kint.2019.09.018 · Cited by 498 · see citing works
Renal Damage in Primary Aldosteronism: Results of the PAPY Study
Rossi, G. P., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., Matterello, M.-J., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000230444.01215.6a · Cited by 470 · see citing works
Self-citationSecondary arterial hypertension: when, who, and how to screen?
Rimoldi, S. F., Scherrer, U., & Messerli, F. H. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht534 · Cited by 393 · see citing works
Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30071-8 · Cited by 347 · see citing works
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347 · see citing works
“A recent multicenter analysis estimated that only 9% to 37% of patients with primary hyperaldosteronism were hypokalemic (276,277).”
BackgroundGenetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma
Fernandes-Rosa, F. L., Williams, T. A., Riester, A., Steichen, O., Beuschlein, F., Boulkroun, S., Strom, T. M., Monticone, S., Amar, L., Meatchi, T., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03419 · Cited by 310 · see citing works
Self-citationGaddam, K., Pimenta, E., Thomas, S. J., Cofield, S. S., Oparil, S., Harding, S. M., & Calhoun, D. A. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2009.96 · Cited by 289 · see citing works
Parthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., Ruilope, L. M., McInnes, G. T., Connell, J. M., & MacDonald, T. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283455ca5 · Cited by 281 · see citing works
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281 · see citing works
Prevalence, Clinical, and Molecular Correlates of <i>KCNJ5</i> Mutations in Primary Aldosteronism
Boulkroun, S., Beuschlein, F., Rossi, G.-P., Golib-Dzib, J.-F., Fischer, E., Amar, L., Mulatero, P., Samson-Couterie, B., Hahner, S., Quinkler, M., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.186478 · Cited by 278 · see citing works
Self-citationJones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.05.007 · Cited by 280 · see citing works
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study
Brown, J. M., Robinson-Cohen, C., Luque-Fernandez, M. A., Allison, M. A., Baudrand, R., Ix, J. H., Kestenbaum, B., de Boer, I. H., & Vaidya, A. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0882 · Cited by 221 · see citing works
Åkerström, T., Crona, J., Delgado Verdugo, A., Starker, L. F., Cupisti, K., Willenberg, H. S., Knoefel, W. T., Saeger, W., Feller, A., Ip, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041926 · Cited by 188 · see citing works
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
Pasquali, R., Casanueva, F., Haluzik, M., van Hulsteijn, L., Ledoux, S., Monteiro, M. P., Salvador, J., Santini, F., Toplak, H., & Dekkers, O. M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0893 · Cited by 180 · see citing works
Connell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0030 · Cited by 182 · see citing works
Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma
Zheng, F.-F., Zhu, L.-M., Nie, A.-F., Li, X.-Y., Lin, J.-R., Zhang, K., Chen, J., Zhou, W.-L., Shen, Z.-J., Zhu, Y.-C., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.03346 · Cited by 151 · see citing works
Di Murro, A., Petramala, L., Cotesta, D., Zinnamosca, L., Crescenzi, E., Marinelli, C., Saponara, M., & Letizia, C. (2010) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310366581 · Cited by 125 · see citing works
Self-citationAhmed, A. H., Gordon, R. D., Taylor, P. J., Ward, G., Pimenta, E., & Stowasser, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1355 · Cited by 96 · see citing works
Primary Hyperparathyroidism With Concurrent Primary Aldosteronism
Maniero, C., Fassina, A., Guzzardo, V., Lenzini, L., Amadori, G., Pelizzo, M. R., Gomez-Sanchez, C., & Rossi, G. P. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.173948 · Cited by 94 · see citing works
Self-citationMild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism
Maniero, C., Fassina, A., Seccia, T. M., Toniato, A., Iacobone, M., Plebani, M., De Caro, R., Calò, L. A., Pessina, A. C., & Rossi, G. P. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f0451 · Cited by 87 · see citing works
Self-citationLaboratory challenges in primary aldosteronism screening and diagnosis
Rehan, M., Raizman, J. E., Cavalier, E., Don-Wauchope, A. C., & Holmes, D. T. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.003 · Cited by 89 · see citing works
Leung, A. A., Symonds, C. J., Hundemer, G. L., Ronksley, P. E., Lorenzetti, D. L., Pasieka, J. L., Harvey, A., & Kline, G. A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19377 · Cited by 89 · see citing works
Rossi, G. P., Ragazzo, F., Seccia, T. M., Maniero, C., Barisa, M., Calò, L. A., Frigo, A. C., Fassina, A., & Pessina, A. C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195891 · Cited by 76 · see citing works
Self-citationThe Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk
Calhoun, D. A., & Sharma, K. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.04.001 · Cited by 74 · see citing works
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism
Šomlóová, Z., Widimský, J., Rosa, J., Wichterle, D., Štrauch, B., Petrák, O., Zelinka, T., Vlková, J., Mašek, M., Dvořáková, J., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.65 · Cited by 68 · see citing works
Lenzini, L., Caroccia, B., Campos, A. G., Fassina, A., Belloni, A. S., Seccia, T. M., Kuppusamy, M., Ferraro, S., Skander, G., Bader, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2900 · Cited by 59 · see citing works
Self-citationO’Shea, P. M., O’Donoghue, D., Bashari, W., Senanayake, R., Joyce, M. B., Powlson, A. S., Browne, D., O’Sullivan, G. J., Cheow, H., Mendichovszky, I., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.13942 · Cited by 58 · see citing works
Börgel, J., Springer, S., Ghafoor, J., Arndt, D., Duchna, H.-W., Barthel, A., Werner, S., Van Helden, J., Hanefeld, C., Neubauer, H., et al. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0148-4 · Cited by 47 · see citing works
Screening for Adrenal-Endocrine Hypertension: Overview of Accuracy and Cost-effectiveness
Schwartz, G. L. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.02.001 · Cited by 36 · see citing works
Lenzini, L., Prisco, S., Vanderriele, P. E., Lerco, S., Torresan, F., Maiolino, G., Seccia, T. M., Iacobone, M., & Rossi, G. P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00143 · Cited by 33 · see citing works
Self-citationBongarzone, S., Basagni, F., Sementa, T., Singh, N., Gakpetor, C., Faugeras, V., Bordoloi, J., & Gee, A. D. (2019) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2018.11.002 · Cited by 31 · see citing works
Role of Ca2+/Calmodulin-Dependent Protein Kinase Kinase in Adrenal Aldosterone Production
Nanba, K., Chen, A., Nishimoto, K., & Rainey, W. E. (2015) · Endocrinology · doi:10.1210/en.2014-1782 · Cited by 27 · see citing works
Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment
Hundemer, G. L. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1185-x · Cited by 27 · see citing works
Asbach, E., Bekeran, M., König, A., Lang, K., Hanslik, G., Treitl, M., Ladurner, R., Bidlingmaier, M., Beuschlein, F., Quinkler, M., et al. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1027-6472 · Cited by 25 · see citing works
Primary aldosteronism in patients with adrenal incidentaloma: is screening appropriate for everyone?
Stavropoulos, K., Imprialos, K. P., Katsiki, N., Petidis, K., Kamparoudis, A., Petras, P., Georgopoulou, V., Finitsis, S., Papadopoulos, C., Athyros, V. G., et al. (2018) · The Journal of Clinical Hypertension · doi:10.1111/jch.13291 · Cited by 23 · see citing works
Inherited Disorders of Renal Salt Homeostasis
Scholl, U. I., & Lifton, R. P. (2013) · Seldin and Giebisch's The Kidney · doi:10.1016/b978-0-12-381462-3.00036-7 · Cited by 10 · see citing works
Kamilaris, C. D. C., & Stratakis, C. A. (2018) · HORMONES · doi:10.1007/s42000-018-0072-y · Cited by 7 · see citing works
- Authors
- Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., Mallamaci, F., Mannelli, M., Mattarello, M.-J., Moretti, A., Palumbo, G., Parenti, G., Porteri, E., Semplicini, A., Rizzoni, D., Rossi, E., Boscaro, M., Pessina, A. C., & Mantero, F.
- Corresponding author
- Rossi, Gian Paolo
- ORCID
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 48
- Issue
- 11
- Pages
- 2293-2300
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2107999636
- Cited by
- 1,467
- References
- 54
- Citations by year
- 2026: 54 · 2025: 82 · 2024: 69 · 2023: 81 · 2022: 94 · 2021: 77 · 2020: 97 · 2019: 101 · 2018: 94 · 2017: 101 · 2016: 87 · 2015: 91 · 2014: 73 · 2013: 66 · 2012: 66
- FWCI
- 26.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- primary aldosteronism, aldosterone-producing adenoma, idiopathic hyperaldosteronism, hypertension, prevalence, adrenal vein sampling, aldosterone-renin ratio, adrenalectomy
- MeSH terms
- Adrenal Cortex Neoplasms, Adrenal Glands, Adult, Aldosterone, Blood Specimen Collection, Female, Humans, Hyperaldosteronism, Hypertension, Male, Middle Aged, Prospective Studies, Radionuclide Imaging, Veins, Prevalence, Adrenocortical Adenoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review